介绍

本页面提供了有关 John C Landgraf 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言,基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是,他们必须通过Form 4向美国证券交易委员会(SEC)报告所有交易。尽管存在这些限制,学术研究表明,整体而言,内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易,排除了作为10b5-1交易计划的一部分的交易。然后,对每笔交易在3、6和12个月的表现进行平均,以生成该笔交易最终的表现指标。然后,将所有交易的表现指标进行平均,计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A",则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易,或者他们进行的交易距离现在时间太近,无法计算出可靠的表现指标。

更新频率:每日

查看收益最高的的内幕交易者列表。

报告内部持仓的公司

美国证券交易委员会(SEC)文件显示John C Landgraf已报告在以下公司拥有持仓或进行了交易:

证券 职位 最新报告的持仓
US:ABT / Abbott Laboratories Executive Vice President 108,972
如何解读这些图表

以下图表显示了在John C Landgraf进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如,如果一笔内部人士交易是在2019年1月1日进行的,该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元,则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%,而从10美元跌至5美元的价格变化将为-50%。

最终,我们将评估内部人士的交易与股价的超额回报(正向或负向)之间的相关性,以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为,我们预期看到(a)买入后的正回报,或者(b)卖出后的负回报。对于情况(a),买入图表将显示一系列向上倾斜的曲线,表示每次买入后都有正回报。对于情况(b),卖出图表将显示一系列向下倾斜的曲线,表示每次卖出后都有负回报。

然而,仅凭这一点还不足以得出结论。例如,如果公司的股价在多年内呈现非周期性上升,我们会预期所有买入后的图表都呈现向上倾斜。同样地,多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下,“买入”图表显示正向信号,而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易,以获得财务优势。

内幕交易历史

该表格显示了由 John C Landgraf 进行的所有内幕交易的完整列表,这些交易已向美国证券交易委员会(SEC)披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化
每股
股价
交易
金额
剩余
金额
2015-03-03 2015-02-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -11,530 108,972 -9.57 47.61 -548,943 5,188,157
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 165,292 165,292
2015-02-24 2015-02-20 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 23,457 120,502 24.17
2015-02-24 2014-06-03 4/A ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -16,289 97,045 -14.37 39.80 -648,302 3,862,391
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -11,956 0 -100.00
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -6,247 0 -100.00
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -16,284 97,050 -14.37 39.80 -648,103 3,862,590
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 11,956 113,334 11.79 32.16 384,456 3,644,357
2014-06-05 2014-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 6,247 101,378 6.57 31.43 196,315 3,185,854
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -807 95,131 -0.84 39.40 -31,797 3,748,257
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -6,307 95,938 -6.17 39.40 -248,496 3,779,957
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -192 102,245 -0.19 39.39 -7,563 4,027,431
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,377 102,437 -1.33 39.38 -54,226 4,033,969
2014-03-04 2014-03-03 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -8,610 103,814 -7.66 39.37 -338,976 4,087,157
2014-03-04 2014-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -15,307 112,424 -11.98 39.79 -609,066 4,473,351
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 154,953 154,953
2014-02-25 2014-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 25,310 127,731 24.71
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Option(right to buy)
M - Exercise 1,583 0 -100.00
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value
S - Sale -600 102,421 -0.58 39.10 -23,463 4,005,173
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value
S - Sale -983 103,021 -0.95 39.10 -38,436 4,028,224
2014-02-19 2014-02-18 4 ABT ABBOTT LABORATORIES
Common Shares without par value
M - Exercise 1,583 104,004 1.55 35.03 55,452 3,643,260
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -21,972 0 -100.00
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value
S - Sale -11,572 102,421 -10.15 36.96 -427,701 3,785,480
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value
S - Sale -10,400 113,993 -8.36 36.95 -384,280 4,212,041
2014-02-11 2014-02-07 4 ABT ABBOTT LABORATORIES
Common Shares without par value
M - Exercise 21,972 124,393 21.45 32.16 706,529 3,999,969
2013-12-20 2013-11-27 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -2,885 102,421 -2.74
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value
105,306
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value
18,398
2013-10-24 3 ABT ABBOTT LABORATORIES
Common shares without par value
166
2013-03-01 2013-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -13,414 105,078 -11.32 34.26 -459,564 3,599,972
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -266 118,492 -0.22 34.78 -9,252 4,121,270
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -2,800 118,758 -2.30 34.78 -97,390 4,130,641
2013-02-20 2013-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -8,616 121,558 -6.62 35.08 -302,249 4,264,255
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 165,000 165,000
2013-02-20 2013-02-15 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 31,700 130,174 32.19
2013-02-13 2012-12-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift 11,614 11,614
2012-12-14 2012-11-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -85 98,474 -0.09
2012-12-14 2012-11-06 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -200 98,559 -0.20
2012-12-14 2012-10-26 4 ABT ABBOTT LABORATORIES
Common shares without par value
G - Gift -90 98,759 -0.09
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 21,972 21,972
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 11,956 11,956
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -7,057 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -17,920 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -13,588 0 -100.00
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -33,928 98,849 -25.55 66.92 -2,270,462 6,614,975
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 7,057 132,777 5.61 53.12 374,868 7,053,114
2012-09-11 2012-09-07 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 31,508 125,720 33.44 53.19 1,675,911 6,687,047
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 6,247 6,247
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -7,156 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -1,823 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -12,835 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -13,439 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -4,935 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -13,270 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -23,000 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -63,800 0 -100.00
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -130,944 94,212 -58.16 65.50 -8,576,832 6,170,886
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -6,247 225,156 -2.70 65.40 -408,554 14,725,202
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 7,156 231,403 3.19 51.21 366,459 11,850,148
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 1,823 224,247 0.82 55.57 101,304 12,461,406
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 12,835 222,424 6.12 58.71 753,543 13,058,513
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 13,439 209,589 6.85 54.30 729,738 11,380,683
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 4,935 196,150 2.58 53.12 262,147 10,419,488
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 13,270 191,215 7.46 53.19 705,831 10,170,726
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 23,000 177,945 14.84 44.16 1,015,680 7,858,051
2012-09-05 2012-08-31 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 63,800 154,945 70.00 46.34 2,956,492 7,180,151
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -30,000 23,000 -56.60
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -30,000 91,145 -24.76 60.00 -1,800,000 5,468,700
2012-03-21 2012-03-19 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 30,000 121,145 32.91 44.16 1,324,800 5,349,763
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Option (right to buy)
M - Exercise -30,000 53,000 -36.14
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,900 91,145 -2.04 58.16 -110,506 5,301,084
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -28,100 93,045 -23.20 58.16 -1,634,296 5,411,497
2012-03-14 2012-03-12 4 ABT ABBOTT LABORATORIES
Common shares without par value
M - Exercise 30,000 121,145 32.91 44.16 1,324,800 5,349,763
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -1,446 91,145 -1.56 56.72 -82,024 5,170,200
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -7,441 92,591 -7.44 56.72 -422,054 5,251,762
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -200 100,032 -0.20 56.72 -11,344 5,673,885
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -100 100,232 -0.10 56.72 -5,672 5,685,179
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -7,700 100,332 -7.13 56.72 -436,752 5,690,931
2012-03-02 2012-02-29 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -10,579 108,032 -8.92 57.04 -603,426 6,162,145
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 55,000 55,000
2012-02-22 2012-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 30,500 118,611 34.62
2006-02-22 2006-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value
S - Sale -310 93,675 -0.33 43.86 -13,597 4,108,586
2006-02-22 2006-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value
F - Taxes -1,146 67,485 -1.67 44.15 -50,596 2,979,463
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Option (right to buy)
A - Award 83,000 83,000
2006-02-22 2006-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value
A - Award 26,500 93,985 39.27 44.16 1,170,240 4,150,378
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value
61,305
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value
14,238
2004-08-05 3 ABT ABBOTT LABORATORIES
Common shares without par value
823
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券(例如股票期权)
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券(例如期权)
V
内部人士通过Form 4自愿报告的一笔交易
J
其他(附有交易描述的脚注)